Is Spinal Cord Stimulation Still Effective After One or More Surgical Revisions?

Neuromodulation 2023 Jul;26(5):1102-1108.doi: 10.1016/j.neurom.2023.03.009. Epub 2023 Apr 19. Aurelie Leplus, Jimmy Voirin, Emmanuel Cuny, Marie Onno, Maxime Billot, Philippe Rigoard, Denys Fontaine Abstract Objectives: Spinal cord stimulation (SCS) is burdened with surgical complications that may require one or several surgical revision(s), challenging its risk/benefit ratio and

The Neuropsychiatric Safety Profile of Lasmiditan: A Comparative Disproportionality Analysis with Triptans

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023 Sep;20(5):1305-1315.doi: 10.1007/s13311-023-01404-1. Epub 2023 Jul 12. Diane Merino, Alexandre O Gérard, Elise K Van Obberghen, Alexandre Destere, Michel Lanteri-Minet, Milou-Daniel Drici Abstract Migraine constitutes the world’s second-leading cause of disability. Triptans, as

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny